1. Home
  2. VOD vs TEVA Comparison

VOD vs TEVA Comparison

Compare VOD & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vodafone Group Plc

VOD

Vodafone Group Plc

N/A

Current Price

$15.66

Market Cap

38.9B

ML Signal

N/A

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

N/A

Current Price

$42.17

Market Cap

40.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VOD
TEVA
Founded
1984
1901
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9B
40.5B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
VOD
TEVA
Price
$15.66
$42.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$16.02
★ $47.92
AVG Volume (30 Days)
3.4M
★ 5.8M
Earning Date
11-10-2026
11-03-2026
Dividend Yield
★ 3.21%
N/A
EPS Growth
N/A
★ 183.45
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.87
N/A
Revenue Next Year
$3.43
$3.56
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.21
$22.70
52 Week High
$17.71
$42.59

Technical Indicators

Market Signals
Indicator
VOD
TEVA
Relative Strength Index (RSI) 45.07 63.40
Support Level $15.67 $38.55
Resistance Level $15.85 N/A
Average True Range (ATR) 0.19 1.07
MACD 0.01 0.05
Stochastic Oscillator 30.67 94.00

Price Performance

Historical Comparison
VOD
TEVA

About VOD Vodafone Group Plc

Vodafone operates mobile and fixed-line networks and businesses across Europe, Africa, and the Middle East. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns two cable networks after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK, Vodafone merged with CK Hutchison in 2024, consolidating the mobile market. It also divested its Spanish and Italian divisions in that same year, given their low returns on invested capital.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: